Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion
- 1 June 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (12) , 1623-1628
- https://doi.org/10.1016/s0002-9149(99)00163-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary InterventionsCirculation, 1996
- Significance of Automated Stenosis Detection During Quantitative AngiographyCirculation, 1996
- Post-intervention cardiac enzyme elevations: Prognostic significance in IMPACT IIJournal of the American College of Cardiology, 1996
- Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts with long-term, low dose direct infusion of urokinase (ROBUST): A serial trialJournal of the American College of Cardiology, 1996
- Angioplasty of complex lesions in ischemic rest angina: Results of the Thrombolysis and Angioplasty in Unstable Angina (TAUSA) TrialJournal of the American College of Cardiology, 1995
- Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: Insights from the coronary angioplasty versus excisional atherectomy trial (CAVEAT)Journal of the American College of Cardiology, 1995
- CAAS II: A second generation system for off‐line and on‐line quantitative coronary angiographyCatheterization and Cardiovascular Diagnosis, 1994
- Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA Trial. TAUSA Investigators. Thrombolysis and Angioplasty in Unstable Angina trial.Circulation, 1994
- Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: Initial results and short-term clinical follow-upJournal of the American College of Cardiology, 1991
- The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.Circulation, 1987